Cleveland Clinic-developed “compound 3” begins testing in preclinical Alzheimer’s model
First-of-its kind study broadens understanding
New center dedicated to studying their role
Finding suggests need for multifront therapeutic approach
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Variants uncovered include ADAMTS6
Insights from the first-ever use of HoloLens in face transplantation
Inhibiting gene expression boosts treatment
Mouse study shows most potent therapeutic ‘drugging’ of microbiome to date
Fostering collaboration between basic, translational scientists and clinicians
Internal award provides funding to cross-disciplinary project
Advertisement
Advertisement